Methotrexate inhibition of muropeptide transporter SLC46A2 controls psoriatic skin inflammation
R. Bharadwaj, C. F. Lusi, S. Mashayekh…·N. Silverman
The paper shows that SLC46A2 transports DAP-muropeptides to activate NOD1 in keratinocytes, and methotrexate inhibits this transport, reducing psoriatic inflammation.